Filing Details

Accession Number:
0001209191-15-020557
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-02 21:16:19
Reporting Period:
2015-03-02
Filing Date:
2015-03-02
Accepted Time:
2015-03-02 21:16:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1011835 Medivation Inc. MDVN Pharmaceutical Preparations (2834) 133863260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1568249 J Jennifer Rhodes C/O Medivation, Inc.
525 Market St., 36Th Floor
San Francisco CA 94105
Gc & Corporate Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-02 2,000 $47.48 14,480 No 4 M Direct
Common Stock Disposition 2015-03-02 2,000 $122.00 12,480 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-03-02 2,000 $0.00 2,000 $47.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
38,000 2022-07-16 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 trading plan.
  2. The shares subject to the option vest according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on July 16, 2013, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest on the first day of each full month thereafter.